Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Ozcelik
T
T
Ozkocaman
V
V
Ozkalemkas
F
F
Ali
R
R
Altundal
Y
Y
Ozkan
A
A
Tunali
A
A
D000368:Aged; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000150:complications / Q000209:etiology*
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D015942:Factor VIIa